<DOC>
	<DOCNO>NCT00762463</DOCNO>
	<brief_summary>This local , multicenter , randomize , active comparator , double-blind , parallel group study extension conduct evaluate efficacy safety celecoxib versus diclofenac SR treatment Chinese patient Ankylosing Spondylitis ( AS ) .</brief_summary>
	<brief_title>Study Of Celecoxib Or Diclofenac For Efficacy Safety In Chinese Patients With Ankylosing Spondylitis</brief_title>
	<detailed_description />
	<mesh_term>Spondylitis</mesh_term>
	<mesh_term>Spondylitis , Ankylosing</mesh_term>
	<mesh_term>Diclofenac</mesh_term>
	<mesh_term>Celecoxib</mesh_term>
	<criteria>Meet 1984 Modified New York Criteria Classification Ankylosing Spondylitis With axial involvement Without peripheral joint involvement ( synovitis ) time study entry , ( exclude involvement hip , knee shoulder ) Need daily treatment NSAIDs previous 30 day study entry Known inflammatory enteropathy ( eg , ulcerative colitis , Crohn 's disease , etc ) Presence extraarticular manifestation ( eg , uveitis , endocarditis , etc . ) Known vertebral compression Need corset study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2011</verification_date>
</DOC>